Trials / Unknown
UnknownNCT05718037
Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine
A Phase I, Randomized, Observer-blinded Study to Evaluate the Safety, Tolerability, and Immunogenicity of BV211 in Adult Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Wuhan BravoVax Co., Ltd. · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This is a phase I, randomized, observer-blinded study to evaluate the safety, tolerability, and immunogenicity of BV211(a herpes zoster vaccine) in Adult Volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Recombinant Zoster Vaccine | 0.5mL, Intramuscular |
| BIOLOGICAL | Placebo | 0.5mL, Intramuscular |
| BIOLOGICAL | Zoster Vaccine Recombinant, Adjuvanted | 0.5mL, Intramuscular |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2024-01-31
- Completion
- 2024-07-31
- First posted
- 2023-02-08
- Last updated
- 2023-02-08
Source: ClinicalTrials.gov record NCT05718037. Inclusion in this directory is not an endorsement.